Arcus Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $234.9M | $71.1M |
| FY2019 | — | $164.0M | $57.9M |
| FY2020 | — | $502.0M | $173.4M |
| FY2021 | — | $842.0M | $148.0M |
| FY2022 | — | $657.0M | $206.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $234.9M | $71.1M |
| FY2019 | — | $164.0M | $57.9M |
| FY2020 | — | $502.0M | $173.4M |
| FY2021 | — | $842.0M | $148.0M |
| FY2022 | — | $657.0M | $206.0M |